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Multivesicular body morphogenesis requires phosphatidyl-
inositol 3-kinase activity
Mar Fernandez-Borja, Richard Wubbolts, Jero Calafat, Hans Janssen, 
Nullin Divecha, Simone Dusseljee and Jacques Neefjes
Multivesicular bodies are endocytic compartments
containing multiple small vesicles that originate from
the invagination and ‘pinching off’ of the limiting
membrane into the luminal space [1–3]. The molecular
mechanisms responsible for the formation of these
compartments are unknown. In the human melanoma
cell line Mel JuSo, newly synthesised major
histocompatibility complex (MHC) class II molecules
accumulate in multivesicular early lysosomes [4]. The
phosphatidylinositol (PI) 3-kinase inhibitor wortmannin
induced the transient vacuolation of early MHC class II
compartments, but also of early and late endosomes.
We demonstrate that endocytic membrane influx is
required for the wortmannin-induced swelling of
vesicles. The wortmannin-induced vacuoles contained a
reduced number of intraluminal vesicles that were
linked to the limiting membrane by membraneous
connections. These data suggest that wortmannin
inhibits the invagination and/or pinching off of
intraluminal vesicles and provide evidence of a role for
PI 3-kinase in multivesicular body morphogenesis. We
propose that the wortmannin-induced vacuolation
occurs as a result of the inability of multivesicular
bodies to store endocytosed membranes as
intraluminal vesicles thereby causing the formation of
large ‘empty’ vacuoles.
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Results and discussion
Wortmannin induces transient swelling of several
endocytic compartments
The PI 3-kinase inhibitor wortmannin has been suggested
to affect vesicular transport in both early and late endo-
cytic compartments [5–7]. In order to study a possible
function of PI 3-kinase in the intracellular transport of
MHC class II molecules, we used stable transfectants of
Mel JuSo cells expressing a chimera of the β chain of the
MHC class II molecule HLA-DR3 fused to green fluores-
cent protein (GFP). This chimera dimerises with the
endogenous MHC class II α chain to form functional
MHC class II–GFP molecules that accumulate in perinu-
clear early lysosomes (Figure 1a) [8]. 
We treated MHC class II–GFP-expressing Mel JuSo cells
with 100 nM wortmannin for various periods of time.
Control and treated cells were fixed and stained for the
mannose-6-phosphate receptor (MPR) (Figure 1). After
30 minutes of wortmannin treatment, large vacuoles
appeared showing strong labelling for MPR on the limit-
ing membrane (Figure 1b). Similarly, transferrin receptor
(TfR)-positive vacuoles were found (data not shown). At
this time point, the morphology of MHC class II–GFP
vesicles was not affected (Figure 1b). After 3 hours of
treatment with wortmannin, the size of the MPR-contain-
ing vesicles was markedly decreased. Cells now contained
large vacuoles where MHC class II–GFP was localised to
the limiting membrane (Figure 1c). Similar effects were
obtained with the structurally unrelated PI 3-kinase
inhibitor LY294002 (data not shown). Wortmannin-
induced MHC class II vacuoles reverted to normal size
vesicles within 5–7 hours after addition of the drug (data
not shown). 
Wortmannin rapidly inactivates in solution [7]. To main-
tain PI 3-kinase inhibition, we added fresh wortmannin
every hour for a total incubation time of 3 hours. This
resulted in the appearance of both MPR and MHC class II
in large vacuoles (Figure 1d). However, the two markers
were mostly segregated and showed only partial colocalisa-
tion, indicating that wortmannin affects different endo-
cytic compartments; similar results were obtained after
TfR detection (data not shown). 
We wondered why wortmannin did not induce vacuola-
tion of all MHC class II–GFP vesicles (Figure 1c). To
assess whether the MHC class II–GFP vacuoles were
typical MHC class II compartments, we examined several
markers by immunofluorescence. The swollen MHC
class II-positive vesicles were negative for the Golgi
markers TGN46 and AP-1 (data not shown), but con-
tained the lysosomal protein CD63 (Figure 2a), a typical
marker for MHC class II compartments [4,8]. The exis-
tence of perinuclear non-swollen vesicles strongly positive
for CD63 indicated that mature lysosomes are not
affected by wortmannin.
After transit through the Golgi, complexes between MHC
class II and the MHC class II-associated invariant chain
(Ii) are sorted to an early lysosomal compartment where
the Ii chain is degraded in a stepwise manner starting with
the luminal portion. Thus, the detection of this fragment
defines early stages in the maturation of MHC class II
compartments [9]. Interestingly, an antibody against the
luminal portion of Ii stained the swollen vacuoles whereas
a large portion of the vesicles that were unaffected in size
were negative (Figure 2b). These results suggested that
the large vacuoles constitute early class II vesicles,
whereas the unaffected CD63-positive vesicles represent
more mature MHC class II compartments.
The same conclusion was drawn from experiments in
which Golgi transport was inhibited by brefeldin A (BFA).
Incubation of cells with BFA and wortmannin caused the
depletion of MHC class II–GFP from the large vacuoles,
still visible as ‘holes’ in the fluorescent background of
MHC class II–GFP that had accumulated in the endoplas-
mic reticulum (Figure 2c). These results suggest that the
swollen MHC class II vesicles constitute an early stage in
the formation of multivesicular MHC class II compart-
ments, whereas the unaffected vesicles are pre-existing
MHC class II compartments. 
Endocytosis is required for the formation of wortmannin-
induced large MHC class II vesicles 
In order to increase the volume of newly formed MHC class
II vesicles, membrane influx is required. The results
obtained from BFA-treated cells indicated that the biosyn-
thetic pathway does not have a major contribution to the
wortmannin-induced swelling. We next investigated the
potential involvement of endocytic membrane influx by
using the antibiotics concanamycin B and bafilomycin A1.
These compounds are selective inhibitors of vacuolar H+-
ATPases and block the delivery of contents from early to
late endosomes [10]. Cells were treated with wortmannin
for 3 hours by adding fresh wortmannin every hour to main-
tain inhibition of PI 3-kinase. Subsequently, endocytic com-
partments were labelled by incubation with the red
fluorochrome sulphorhodamine 101 (SR101) for 30 minutes
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Figure 1
Wortmannin induces transient vacuolation of endocytic compartments.
Mel JuSo cells expressing MHC class II–GFP were treated with 100 nM
wortmannin for (a) 0 min, (b) 30 min or (c,d) 3 h. In (d), fresh wortmannin
was added every hour. Cells were fixed and examined for MHC class
II–GFP distribution (shown in green); the mannose-6-phosphate receptor
(MPR) was detected by immunostaining (shown in red). (a) Both MHC
class II–GFP and MPR distributed in juxtanuclear vesicles but did not
colocalise. (b) Large vacuoles containing MPR appeared 30 min after
the addition of wortmannin, while most of the MHC class II
compartments remained unaffected. (c) After 3 h treatment with
wortmannin, however, MHC class II compartments appeared vacuolated,
whereas no large MPR-containing vesicles were observed. (d) When
wortmannin was refreshed during the 3 h incubation, both MHC 
class II–GFP and MPR localised to large vacuoles but showed non-
overlapping distributions.
Figure 2
Wortmannin affects early MHC class II compartments. (a,b) Cells
expressing MHC class II–GFP were treated with 100 nM wortmannin for
3 h, fixed and incubated with (a) anti-CD63 or (b) anti-invariant chain (Ii)
antibodies followed by secondary antibodies conjugated with Texas red.
MHC class II localisation is shown in green, CD63 and Ii in red, and
colocalisation in yellow. CD63 concentrated in MHC class II-positive
vesicles that were unaffected by wortmannin and localised close to the
nucleus. The large vacuoles also contained CD63 but in lower amounts.
Predominantly swollen MHC class II vesicles contained the luminal
fragment of the Ii. (c) Cells expressing MHC class II–GFP were incubated
with 100 nM wortmannin (WT) with 2 µg/ml BFA. The addition of BFA
resulted in the depletion of MHC class II–GFP from the wortmannin-
induced vacuoles, but not from the vesicles unaffected by the drug. 
(a) CD63 (b) Ii (C-ter) (c) WT+BFA
10 µm
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and cultured for an additional 60 minutes in the absence of
SR101. The marker reached enlarged MHC class II com-
partments as well as the wortmannin-insensitive ones
(Figure 3a). This indicates that, even in the constant pres-
ence of wortmannin, neither fluid-phase endocytosis nor
endocytic traffic are markedly blocked (note that the marker
reached unaffected mature MHC class II compartments).
When concanamycin B was added to the cells together with
wortmannin for 3 hours, SR101 accumulated in tubulovesic-
ular early endosomes and, surprisingly, no swollen vesicles
were observed (Figure 3b). Identical results were obtained
with bafilomycin A1 (data not shown).
To further confirm the contribution of endocytic mem-
brane inflow to the swelling of MHC class II compart-
ments, we microinjected Myc-tagged wild-type Rab5 or
S34N Rab5 DNA in the nucleus of MHC class II–GFP
cells. Overexpression of the mutant S34N Rab5 impairs
endosome fusion and blocks the early endocytic pathway
[11,12]. Five hours after microinjection, cells were incu-
bated with wortmannin for 3 hours, fixed and stained with
the anti-Myc antibody 9E10. Cells overexpressing the
mutant Rab5 did not show any ‘swollen’ vesicles in con-
trast to the neighbouring non-injected cells (Figure 3c).
Overexpression of wild-type Rab5 had no effect and cells
responded to the wortmannin treatment in the same way
as the non-injected cells (data not shown). These results
suggest that incoming membranes from earlier endocytic
compartments contribute to the wortmannin-induced
swelling of MHC class II vesicles.
Wortmannin inhibits multivesicular body biogenesis
In Mel JuSo cells, MHC class II compartments are
densely packed multivesicular structures in which MHC
class II molecules and CD63 distribute in the internal
membranes (Figure 4a) [8]. In contrast, wortmannin-
treated cells showed large vacuoles that labelled for MHC
class II β chain and CD63 and contained few intraluminal
vesicles (Figure 4b). In addition, we repeatedly observed
that these internal vesicles were grouped in close proxim-
ity to the limiting membrane, and occasionally connected
to this membrane. 
In order to obtain better ultrastructural information on the
Z-direction, we analysed embedded sections of wortman-
nin-treated cells by tilting the specimens ±30° under the
electron beam. This technique allowed us to visualise the
existence of stalks connecting the internal vesicles to the
perimeter membrane (Figure 4c–h). These observations
suggest that wortmannin inhibits the process of ‘inbud-
ding’ and/or the scission of newly formed intraluminal
vesicles. The swelling is unlikely to be the result of inhi-
bition of further vesicular transport since later compart-
ments are still accessible to fluid-phase markers. As we
have shown that the swollen vesicles represent an early
stage in the maturation of MHC class II compartments, we
propose that PI 3-kinase activity is required for the mor-
phogenesis of multivesicular MHC class II compartments
as well as other multivesicular endocytic compartments
(recycling endosomes, late endosomes). It is most likely
that morphology is related to sorting within the compart-
ment and trafficking, which would explain previous
results on inhibition of MPR and TfR trafficking by wort-
mannin [5,7]. In fact, both cycling receptors are sorted to
internal membranes [2,13,14]. Similarly, Kobayashi et al.
[15] showed that internal membranes of multivesicular
bodies are enriched in the lipid lysobisphosphatidic acid.
The product generated by PI 3-kinase on the limiting
membrane of multivesicular bodies could recruit and/or
activate the molecular machinery necessary for the inbud-
ding process generating intraluminal vesicles. Interest-
ingly, two recent publications by Emr and colleagues
[16,17] suggest that the degradation of PI(3)P occurs in
the vacuolar lumen after sorting of the lipid into vesicles
generated by invagination of the vacuolar limiting mem-
brane, further underscoring the importance of PI metabo-
lism in multivesicular body formation. 
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Figure 3
Endocytosis is required for the wortmannin-induced vacuolation.
(a) Cells were treated with 100 nM wortmannin for 3 h adding fresh
wortmannin every hour. For the last 90 min, cells were allowed to
internalise the fluid phase endocytic marker SR101 (30 min pulse and
60 min chase). A large fraction of the MHC class II–GFP vacuoles as
well as the more central unaffected vesicles contained SR101.
(b) When concanamycin B (con B; 20 nM) was added together with
wortmannin, SR101 accumulated in tubulovesicular structures, which
are characteristic of early endosomes, and no large vacuoles appeared.
In (a,b), MHC class II localisation is shown in green and SR101 in red.
(c) Myc-tagged dominant-negative mutant Rab5 cDNA was injected in
the nucleus of cells expressing MHC class II–GFP. After 3 h culture,
cells were incubated with wortmannin for 3 h, fixed and the Myc tag
was detected by immunostaining. Inhibition of endocytosis by
overexpression of dominant-negative Rab5 prevented wortmannin-
induced vacuolation. MHC class II localisation is shown in green and
Rab5 in red.
(a) SR101 (90 min) (b) Con B (c) S34N Rab5
10 µm
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Figure 4
Wortmannin inhibits a process involved in the
morphogenesis of multivesicular bodies.
Cryosections of (a) untreated and
(b) wortmannin-treated MHC class II–GFP-
expressing cells were labelled with anti-CD63
(5 nm gold, small arrows) and anti-MHC
class II β chain (10 nm gold, large arrows).
(a) For the multivesicular class II
compartments in untreated cells, note the
dense patching of the internal vesicles that
contain most of the CD63 labelling (80% of
the total). (b) The wortmannin-induced
vacuole contains a few internal vesicles in
close proximity to the limiting membrane, with
60% of the total CD63 labelling concentrated
in the internal vesicles. G, Golgi apparatus;
er, endoplasmic reticulum. (c–h) Sections of
LX112/araldite-embedded samples were
analysed by tilting the specimen ±30° in the
electron microscope: (c,f) –30°; (d,g) 0°;
(e,h) +30°. (c–e) A wortmannin-induced
large vacuole is shown that contains a few
internal vesicles connected to the limiting
membrane and linked to each other by thin
stalks (arrows). The images in (f–h) are a
higher magnification of the area indicated by
the arrows in (c–e), respectively. Bars
represent 200 nm.
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